Cargando…
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
PURPOSE: Glioblastoma (GBM) has a poor prognosis after standard treatment. Recently, metformin has been shown to have an antitumor effect on glioma cells. We performed the first randomized prospective phase II clinical trial to investigate the clinical efficacy and safety of metformin in patients wi...
Autores principales: | Yoon, Wan-Soo, Chang, Jong Hee, Kim, Jeong Hoon, Kim, Yu Jung, Jung, Tae-Young, Yoo, Heon, Kim, Se-Hyuk, Ko, Young-Cho, Nam, Do-Hyun, Kim, Tae Min, Kim, Se Hoon, Park, Sung-Hae, Lee, Youn Soo, Yim, Hyeon Woo, Hong, Yong-Kil, Yang, Seung Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244311/ https://www.ncbi.nlm.nih.gov/pubmed/37278858 http://dx.doi.org/10.1007/s12672-023-00678-3 |
Ejemplares similares
-
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
por: Ahn, Grace S., et al.
Publicado: (2022) -
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
por: Hwang, Kihwan, et al.
Publicado: (2020) -
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013) -
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017) -
Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
por: Bae, So Hyun, et al.
Publicado: (2014)